COVID-19 Vaccines: Authorized for Emergency Use
Latest Updates: (01/18/2021)
- Astra Zeneca vaccine received another approval in Brazil on Jan 17.
- A new vaccine called CoronaVac from Sinovac also received approval on Jan 17 in Brazil.
Initial Approvals Matrix:
A quick snapshot of vaccines approved globally for use -
| Company | Region | Authorization | Trial Population | Efficacy | Doses | Storage |
| Pfizer-BioNTech | UK | 12/2/2020 | >40,000 subjects | 95% | 2 | minus 70 degrees C |
| US | 12/11/2020 | |||||
| EU | 12/21/2020 | |||||
| WHO | 12/31/2020 | |||||
| Moderna | US | 12/18/2020 | 30,000 subjects | 94.50% | 2 | minus 20 degrees C 6 months |
| UK | 01/08/2021 | |||||
| Astra-Zeneca | UK | 12/30/2020 | 20,000 volunteers | |||
| Argentina | 12/30/2020 | |||||
| India | 01/02/2021 | 1600 subjects | 62% | 2 | 2 to 8 degrees C (refrigerator) | |
| Bharat Biotech | India | 01/03/2021 | 22,500 subjects | unknown | 2 |